104 – Advanced Drug Delivery Systems (S7E14)

Welcome back to the Deep Dive, everybody. Today
we're taking a look at something that's really
changing the game in medicine, how we get drugs
into the body. We're not talking your everyday
pills and shots. This is next level stuff. Exactly.
We're going to be diving into some seriously
advanced drug delivery systems, think nano carriers,
liposomes, even implantable devices. You've given
me some fascinating research on this, like cutting
edge scientific papers and even regulatory documents.
So our mission today. It's pretty simple, really.
We want to break down the science behind these
new technologies, understand how they work, why
they're better than the old ways of doing things,
and how they're already being used in the real
world to help patients. And we're going to do
this in a way that everyone can understand, whether
you're a scientist yourself or just curious about
the future of medicine. Right. But before we
get into the real cool stuff, it might be useful
to start with the basics. Why do we even need
these fancy new systems? What's wrong with the
way we deliver drugs now? I mean, we've been
using pills and injections for ages. Sure, sure.
Well, the main problem with traditional methods
like pills and injections is they just kind of
spread the drug everywhere in the body. Like
a shotgun approach. Yeah, exactly. They get into
the bloodstream and go everywhere. The problem
is this can lead to side effects because the
drug ends up in places where it's not needed,
affecting healthy tissues and organs. OK. That
makes sense. And you often need to take higher
doses or take the drug more often to make sure
enough of it reaches the actual problem area.
Exactly. And that's where these advanced drug
delivery systems come in. They offer a much more
targeted and controlled approach. And this is
going to be the focus of our conversation today.
OK, so let's dive into the specifics, starting
with nano carriers. Now, the prefix nano always
throws me off. We're talking really, really tiny
here, right? What's the basic science behind
how these nano -carriers work? Well, nano -carriers
are incredibly small particles engineered at
the molecular level to carry drugs directly to
where they're needed. They're often made from
a combination of materials like polymers and
lipids. Polymers and lipids? That sounds like
a strange mix. It's actually a pretty clever
strategy. See, polymers can give the nano -carrier
structure and control how quickly the drug is
released, while lipids help the nano -carrier
interact with some membranes. So it's like building
a tiny customizable delivery vehicle. Exactly.
And their size, being so small, it allows them
to do things that traditional drug delivery methods
just can't. Speaking of size, I remember reading
about something called the enhanced permeation
and retention effect, or EPR effect, especially
for cancer treatment. What did that mean exactly?
Yeah, that's a really cool phenomenon. You see,
in a lot of diseased tissues, particularly tumors,
the blood vessels are kind of leaky and disorganized.
They're not as tightly packed as they are in
healthy tissue. And the lymphatic drainage in
these areas isn't as efficient either. Now, because
nano -carriers are so tiny, they can actually
slip through these leaky blood vessels and into
the tumor. And once they're in there, they tend
to hang around for a while because they're not
easily cleared away. So it's like they have a
VIP pass to get into the tumor and then they
just set up camp. Yeah, kind of. This is the
EPR effect in action. It allows a higher concentration
of the drug to build up inside the tumor while
minimizing exposure to healthy cells. That's
incredible. It's like delivering a knockout punch
directly to the cancer cells without harming
the rest of the body. You actually shared a paper
that had a really cool example of this. Something
about nanoparticles targeting a specific protein
called CD98 to treat colitis in mice. What's
the story there? Ah, yes. That was a fascinating
study. It's a perfect example of how targeted
therapy can work at the molecular level. In this
case, the researchers created nanoparticles with
antibodies on their surface, specifically designed
to bind to the CD98 protein. Okay, so CD98 is
like a beacon for the nanoparticles to home in
on. Right. CD98 is found in larger amounts in
inflamed tissues, like those affected by colitis.
The nanoparticles were also loaded with something
called small interfering RNA, or CERNA. What
does CERNA do? It's like a gene silencer. It
basically turns off the activity of the CD98
gene, which is thought to play a role in the
inflammation. So when these nanoparticles are
injected, they find their way to the inflamed
colon, latch on to the CD98 protein, and release
the serine, and the result, reduced inflammation
in the mice. Wow, that's incredible. It's almost
like sending a tiny surgeon in there to turn
off the inflammation at its source. Yeah. But
being so tiny, doesn't working at the nanoscale
raise concerns about safety? I mean, one of your
sources mentioned possible toxicity issues with
nanoparticles. Yeah, that's a very valid point.
You're right. Because nanoparticles are so small,
we need to be extra careful about their potential
effects on the body. We have to look at everything.
what they're made of, their size and shape, the
charge on their surface, and even how they break
down and are cleared from the body. So it's not
just about making them work, it's about making
sure they're safe. Exactly. Researchers are working
hard to address these safety concerns. They're
looking at whether nanoparticles might build
up in certain organs, cause unwanted immune reactions,
or interfere with normal cell processes. This
careful research is vital to ensure that any
nanoparticles used in medicine are safe and effective.
Okay, that makes sense. Let's move on to another
type of advanced drug delivery system. Liposomes.
When I hear liposome, I think of tiny bubbles
of fat. Am I on the right track? You're pretty
close, actually. Liposomes are essentially tiny
sacs made from lipids, which are fats. They have
a structure very similar to the membranes that
surround our own cells. So they're like tiny
little cells themselves. In a way, yes. They
have these double layers of fat molecules called
lipid bilayers, and they form a sphere with a
watery core. This structure is what makes them
so versatile. They can carry water soluble drugs
in their core and fat soluble drugs within the
lipid layers. So they're like a two for one deal
for drug delivery. What other advantages do liposomes
offer? Well, for starters, they can significantly
improve the solubility of drugs. You see, a lot
of drugs have trouble dissolving in water, which
makes them hard for the body to absorb. Liposomes
can encapsulate these drugs, making them easier
to disperse and absorb. Like hiding a pill inside
a spoonful of peanut butter. Yeah, kind of. But
liposomes offer other benefits, too. They protect
the drug from being broken down too quickly by
enzymes in the bloodstream. And, similar to nano
-carriers, their surface can be modified with
targeting molecules to deliver the drug to specific
cells or tissues. So, we could design liposomes
to specifically target cancerous cells or areas
of inflammation, just like those CD98 targeting
nanoparticles we discussed. You got it! Liposomes
are already being used clinically for various
applications, especially in cancer and fungal
infections. Liposomal formulations of these drugs
often work better and have fewer side effects
than traditional formulations. So they're already
out there making a difference. All right, let's
move on to the last type of advanced drug delivery
system we're discussing today. Implantable devices.
This sounds like a way to deliver drugs over
a long period. How do these devices work? Implantable
devices are pretty much what they sound like.
They're devices that are surgically implanted
in the body to release medication over an extended
period, sometimes months or even years. So it's
like having a tiny pharmacy inside you. Yeah,
that's a good way to think about it. There are
different types of implantable devices. Some
use a reservoir filled with the drug and a membrane
that lets the drug slowly seep out. Others use
a biodegradable polymer matrix that gradually
breaks down and releases the drug over time.
And there are even implantable pumps that can
be programmed to release the drug at specific
intervals. Wow, that's pretty high tech. What
are the main benefits of using these implantable
devices? There are several. For one, they drastically
reduce how often you need to take medication.
This can be a huge improvement for people with
chronic conditions who have to take medication
every day. Imagine only needing an implant once
a year instead of taking pills every day. That
would be amazing. Right. Implantable devices
also provide a very steady and consistent release
of the drug, avoiding those ups and downs you
get with traditional methods. And because they
can deliver the drug directly to the site where
it's needed, they can reduce side effects by
limiting the drug's exposure to the rest of the
body. That makes sense. I imagine this would
be especially beneficial for powerful drugs that
have a lot of potential side effects. Precisely.
For example, you can imagine an implant placed
right next to a tumor that delivers a high dose
of chemotherapy directly to the cancer cells,
minimizing damage to healthy tissues. Now, our
source material didn't delve into specific examples
of implantable devices, but I'm thinking things
like insulin pumps for diabetes or contraceptive
implants. Are those good examples? Absolutely.
Those are great examples of implantable devices
that are already being used successfully to manage
chronic conditions and deliver hormones over
extended periods. There are also implantable
devices that deliver pain medication directly
to the spinal cord. The potential applications
are vast and expanding all the time. OK, so we've
covered the three main types of advanced drug
delivery systems. Nano carriers, liposomes, and
implantable devices. Let's circle back to those
advantages over traditional methods that we mentioned
earlier, improved efficacy, reduced side effects,
and targeted therapy. Can we break down how those
are achieved with these specific systems in mind?
Sure. So when we talk about improved efficacy,
we're basically saying that these new systems
can deliver the drug more effectively to the
right place, allowing you to use a lower overall
dose. Think back to that colitis example with
the CD98 targeting nanoparticles. Delivering
the Serenade directly to the inflamed colon was
much more effective and required less drug overall
than giving a traditional drug that would spread
throughout the whole body. Right. It's all about
precision and hitting the target without wasting
medication or causing unnecessary side effects.
And that's exactly how these systems lead to
fewer side effects. By minimizing exposure of
healthy tissues to the drug, you reduce the chance
of those tissues being harmed. So targeted delivery
keeps the drug focused on the problem area. like
a laser beam instead of a floodlight. Perfect
analogy. And the concept of targeted therapy
really shines here. We're talking about designing
drug delivery systems that can seek out and interact
with specific cells or tissues, like those nanoparticles
honing in on the CD98 protein in colitis. It's
incredible to think that we can design therapies
with that level of precision. OK, so we've talked
about cancer and inflammatory diseases, but what
other areas hold promise for these advanced drug
delivery systems? Are there other diseases that
could benefit from this technology? Oh absolutely.
While our source is focused on cancer and inflammation,
the potential applications go way beyond those
areas. Researchers are looking at using these
systems for infectious diseases, delivering antimicrobials
directly to the site of infection. And there's
a lot of interest in using them for neurological
disorders, potentially helping drugs cross the
blood -brain barrier, which is notoriously difficult
to penetrate. Wow. That would be a game changer
for treating conditions like Alzheimer's and
Parkinson's. It could be. And these systems are
also being explored and regenerative medicine,
delivering growth factors or genetic materials
to specific cells to help repair and regrow tissues.
It's a really exciting field with new applications
emerging all the time. This all sounds incredibly
promising, but let's talk about the practical
side of getting these innovations to patients.
I'm guessing the regulatory process for these
advanced systems is pretty complex. Oh, definitely,
especially when these systems are classified
as medical devices, which is often the case for
implantable devices or even software that controls
drug release. They fall under the watchful eye
of agencies like the U .S. FDA, specifically
their Center for Device and Radiological Health
or CDRH. These devices have to go through rigorous
testing and meet strict safety standards before
they can be used on patients. So it's not just
about developing the technology, it's about making
sure it's safe and effective for people. And
with AI, becoming more prevalent in healthcare,
especially in areas like software as a medical
device or SAMD? Are there specific regulatory
hurdles for that, especially when it comes to
controlling drug delivery? Yeah, you've hit on
a really important point. AI in healthcare is
a rapidly evolving field, and regulations are
constantly being updated to keep pace. When it
comes to SAM and DS, agencies like the FDA are
focusing on things like how the software is classified
based on its risk level, how it's designed and
developed, whether it works on its own or with
other medical devices, cybersecurity to protect
patient data, how it's used in clinical settings,
and the specific algorithms it uses. And of course,
they want to make sure that AI -powered medical
devices are transparent, explainable, and most
importantly, safe for patients. Exactly. It's
a complex landscape, but having clear regulations
is crucial to ensure that these technologies
are used responsibly and ethically. OK, so we've
talked about the technology, the potential applications,
and the regulatory landscape. Now, let's shift
gears a bit and talk about how these advanced
delivery systems affect the way drugs behave
inside the body. One of the sources mentioned
something called pharmacokinetics, specifically
drug distribution and protein binding. Can you
explain what that means? Sure. Pharmacokinetics
is basically the study of what happens to a drug
from the moment it enters the body until it leaves.
It looks at how the drug is absorbed, distributed,
metabolized, or broken down and excreted. Now
these advanced delivery systems can actually
change how these processes work. Really? How
so? Well, for example, if a drug is encapsulated
in a nanoparticle, it might be distributed differently
in the body compared to the drug on its own.
It might stay in the bloodstream longer, or it
might accumulate in specific tissues thanks to
those targeting molecules we talked about earlier.
And I remember reading that drugs that bind strongly
to proteins in the blood tend to stay in the
bloodstream and have a limited distribution.
How do these new delivery systems affect that?
That's an important point. Only the unbound portion
of a drug can really interact with its target
and have its intended effect. Advanced delivery
systems can actually change how much of a drug
is bound to proteins. For example, a nanoparticle
might shield the drug from binding to proteins,
making more of it available to do its job. Or
the delivery system itself might bind to proteins,
which could change how the drug is distributed.
So it's not just about getting the drug to the
right place. It's also about making sure it's
in the right form to work properly. Exactly.
That's why pharmacokinetic studies are so important
for these new drug delivery systems. They help
us understand exactly how the drug and its delivery
system behave inside the body, so we can design
them better and figure out the best doses to
use. Okay, last but not least, let's talk about
the manufacturing of these advanced drug delivery
systems. They seem pretty complex to make. What
are some of the key considerations for manufacturing
and quality control to ensure consistency and
reliability? Manufacturing and quality control
are super important for any drug product, but
even more so for these advanced systems because
they're so complex. We need to make sure that
every batch of nano carriers, liposomes, or implantable
devices is made exactly the same way and has
the same properties, the right size, the right
amount of drug, the right release rate, and so
on. This requires really tight control over the
manufacturing process and rigorous quality checks
at every stage. I imagine there's little room
for error when you're dealing with such tiny
components in complex formulations. Right. And
that's where the concept of quality by design
comes in. It's all about understanding the product
and the manufacturing process inside and out,
figuring out what factors can affect quality,
and designing the process to make sure every
batch meets the same high standards. This helps
ensure that patients receive a safe and effective
product every time. So to wrap things up, it's
clear that we're witnessing a major shift in
how we deliver drugs to the body. These advanced
drug delivery systems offer incredible potential
for improving patient care. Absolutely. We've
gone from a one -size -fix -all approach to a
more personalized and targeted strategy, and
that's a huge step forward. And the coolest part
is that we're seeing these advancements translate
into real -world benefits for patients, like
improved efficacy, fewer side effects, and the
possibility of targeting therapies with incredible
precision. And remember, this is just the tip
of the iceberg. The field of drug delivery is
constantly evolving. And who knows what amazing
breakthroughs await us in the future. Exactly.
Yeah. It's a truly exciting time to be following
these developments. So as we end our deep dive
today, here's a final thought for our listeners
to ponder. With these advanced systems poised
to revolutionize how we treat diseases, what
broader impacts might they have on the future
of health care? How will they change the way
we think about disease management and patient
care? It's a fascinating question and one that
deserves careful consideration as these technologies
continue to advance. A big thank you to everyone
for tuning into this deep dive. We hope you found
it insightful and engaging. And as always, keep
those questions coming and stay curious at the
world around you. Until next time, take care
and stay informed.